APA (7th ed.) Citation

K, M., K, M., S, N., F, O., H, W., H, S., . . . M, S. (2026). Morphologic Leukemia-Free State after Venetoclax-Based Therapy in Acute Myeloid Leukemia is Associated with High Relapse Despite Preserved Short-Term Survival. Mediterranean journal of hematology and infectious diseases, 18(1), e2026048. https://doi.org/10.4084/MJHID.2026.048

Chicago Style (17th ed.) Citation

K, Motegi, Miyao K, Negishi S, Ohara F, Wakabayashi H, Sawa H, Inagaki Y, and Sawa M. "Morphologic Leukemia-Free State After Venetoclax-Based Therapy in Acute Myeloid Leukemia Is Associated with High Relapse Despite Preserved Short-Term Survival." Mediterranean Journal of Hematology and Infectious Diseases 18, no. 1 (2026): e2026048. https://doi.org/10.4084/MJHID.2026.048.

MLA (9th ed.) Citation

K, Motegi, et al. "Morphologic Leukemia-Free State After Venetoclax-Based Therapy in Acute Myeloid Leukemia Is Associated with High Relapse Despite Preserved Short-Term Survival." Mediterranean Journal of Hematology and Infectious Diseases, vol. 18, no. 1, 2026, p. e2026048, https://doi.org/10.4084/MJHID.2026.048.